# Piperacillin and Tazobactam

NDC: 63323-304
Generic name: Piperacillin Sodium and Tazobactam Sodium
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20110531

FDA application: ANDA090498

## Active ingredients

- PIPERACILLIN SODIUM: 36 g/180mL
- TAZOBACTAM SODIUM: 4.5 g/180mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-304"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-304
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e53ebafc-3afa-4a1e-9313-fecd1c1c5d7c